Mcgill University Health Centre/research Institute Of The Mcgill University Health Centre
Clinical trials sponsored by Mcgill University Health Centre/research Institute Of The Mcgill University Health Centre, explained in plain language.
-
Can we give COVID and flu shots together? new study for vulnerable patients
⭐️ VACCINE ⭐️ Recruiting nowThis study looks at the best way to give COVID-19 booster and flu shots to people with weakened immune systems (like those with rheumatoid arthritis, organ transplants, or HIV). It will compare getting both vaccines on the same day versus one month apart, and also test if getting…
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: ⭐️ VACCINE ⭐️
Last updated May 08, 2026 12:01 UTC
-
Diabetes drug may boost dialysis efficiency in kidney failure patients
Disease control Recruiting nowThis study tests whether canagliflozin, a diabetes medicine, can help people on peritoneal dialysis remove more fluid and reduce scarring of the belly lining. About 30 adults with kidney failure will receive either the drug or a placebo for 26 weeks, then switch. The goal is to s…
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 16, 2026 23:57 UTC
-
Partner up! new study tests if couples who walk together control diabetes better
Disease control Recruiting nowThis study tests whether adding couples counseling to a step-counting program helps people with type 2 diabetes walk more and improve blood sugar. About 200 couples will join. Half will get step counters and step goals from their doctor, plus counseling sessions to improve commun…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 16, 2026 23:56 UTC
-
New study aims to make food allergy treatment safer and more tolerable
Disease control Recruiting nowThis study tests different versions of oral immunotherapy (OIT) for people with peanut, milk, or egg allergies. The goal is to see if using lower doses or processed allergens can reduce the risk of severe allergic reactions during treatment while still helping patients become les…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 16, 2026 23:55 UTC
-
New pacing technique could cut heart failure risks in pacemaker patients
Disease control Recruiting nowThis study tests if a newer pacing method, left bundle branch pacing, is better than the standard right ventricular pacing for people with heart block who need a pacemaker. Standard pacing can sometimes weaken the heart over time, leading to heart failure or death. The study will…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 16, 2026 23:53 UTC
-
Could less be more? new study tests lower doses for Crohn's and colitis
Disease control Recruiting nowThis study looks at whether people with Crohn's disease or ulcerative colitis who are in deep remission can safely reduce how often they take the biologic drug ustekinumab. Researchers will monitor blood levels, inflammation, and gut health to see if a lower dose still keeps the …
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 16, 2026 23:52 UTC
-
New study aims to outsmart recurring c. diff infections
Disease control Recruiting nowThis study compares two treatments to prevent Clostridioides difficile (C. diff) infection from returning. About 500 adults with a first or second C. diff episode will receive either a vancomycin taper or a 10-day course of fidaxomicin. The goal is to see if the vancomycin taper …
Phase: PHASE3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 16, 2026 23:38 UTC
-
Can a diabetes drug protect hearts in kidney failure?
Disease control Recruiting nowThis study tests whether canagliflozin, a drug used for diabetes, can improve heart structure in people with advanced kidney disease (stages 4 and 5) or those on dialysis. About 92 participants will receive either the drug or a placebo, and heart changes will be measured using MR…
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Could a common blood thinner beat a deadly staph infection?
Disease control Recruiting nowThis study looks at whether switching to a blood thinner called dabigatran can help people with a serious staph bloodstream infection. Participants are already taking a different blood thinner for conditions like atrial fibrillation or blood clots. The goal is to see if dabigatra…
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 11, 2026 20:54 UTC
-
Social prescription: a new way to help women with heart failure stick to meds
Disease control Recruiting nowThis study tests whether social prescribing—a program that connects patients to community resources like housing, transportation, or mental health support—can help women with heart failure take their medications as prescribed and improve their quality of life. About 200 women wit…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
Vancomycin shield may stop c. diff from coming back during antibiotic treatment
Disease control Recruiting nowThis study tests whether taking oral vancomycin can prevent a repeat Clostridioides difficile infection in people who recently had one and now need another antibiotic. About 300 adults will be randomly assigned to receive vancomycin or a placebo while on other antibiotics and for…
Phase: PHASE2, PHASE3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Apr 26, 2026 19:38 UTC
-
No-Needle liver test could spare thousands from painful procedures
Diagnosis Recruiting nowThis study looks at whether measuring spleen stiffness with ultrasound can safely detect and track dangerous liver pressure (portal hypertension) in people with advanced chronic liver disease. About 200 adults will have regular non-invasive scans instead of the usual invasive nee…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Diagnosis
Last updated May 16, 2026 23:57 UTC
-
Shorter TB prevention pill regimens aim to boost completion and safety
Prevention Recruiting nowThis study tests whether shorter daily pill regimens (1–2 months) can safely prevent latent tuberculosis infection from turning into active disease. About 1,800 adults and children with a positive TB test will take one of several experimental pill combinations or the standard 4-m…
Phase: PHASE2, PHASE3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Prevention
Last updated Apr 24, 2026 16:18 UTC
-
Can a higher dose of a sedative keep your arm numb longer after surgery?
Symptom relief Recruiting nowThis study tests three different doses of a drug called dexmedetomidine, added to the usual numbing medicine for a nerve block in the armpit area. The goal is to see if a higher dose can keep the arm numb and pain-free longer after elbow or hand surgery. About 69 adults having up…
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Symptom relief
Last updated May 16, 2026 23:57 UTC
-
Breathe easy: simple breathing exercise may speed concussion recovery in youth
Symptom relief Recruiting nowThis study tests whether doing a 10-minute paced breathing exercise every day for four weeks can help children and teens (ages 9-18) recover from a concussion. Participants either do the breathing exercises at home or receive usual care. The main goal is to see if the program is …
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Symptom relief
Last updated May 16, 2026 23:54 UTC
-
Fertility treatment's hidden toll on sex life revealed
Knowledge-focused Recruiting nowThis study looks at how infertility and fertility treatments like IVF affect women's sexual function and behavior. About 500 women under 45 with infertility will fill out an anonymous questionnaire about their sexual desire, satisfaction, and activities. The goal is to help docto…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated May 16, 2026 23:54 UTC
-
Finger prick blood test could make inflammation monitoring easier
Knowledge-focused Recruiting nowThis study checks if a simple finger prick (dried blood spot) can measure inflammation markers as well as a standard blood draw from a vein. About 50 adults who are getting a vaccine or have a planned stressor will give both types of samples. The goal is to see if the finger-pric…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated May 16, 2026 23:53 UTC
-
Home workouts before kidney transplant: a feasibility test
Knowledge-focused Recruiting nowThis study tests whether a 12-week virtual exercise and education program is practical for people waiting for a kidney transplant. It will enroll 30 pre-frail or frail adults. The goal is to see how many people sign up, stick with the program, and complete follow-ups, not to meas…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated May 16, 2026 23:51 UTC
-
Blood test may slash unnecessary antibiotic use in ICUs
Knowledge-focused Recruiting nowThis study is testing whether a special blood test (biomarker signature) can help doctors in intensive care units (ICUs) make better decisions about when to use antibiotics. About 1,200 ICU patients who have started antibiotics will be randomly assigned to have their treatment gu…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
Prison needle exchange study aims to curb HIV and hepatitis c behind bars
Knowledge-focused Recruiting nowThis study aims to increase the use of needle and syringe programs in Canadian federal prisons to reduce the spread of HIV and hepatitis C among people who inject drugs. Researchers will work in nine prisons, including five women's prisons, to identify barriers and test strategie…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
Bubble sounds may reveal how well preemies breathe
Knowledge-focused Recruiting nowThis study looks at 30 premature babies on bubble CPAP, a breathing machine. Researchers want to see if the bubbling sounds can tell them if the right air pressure is being delivered. The goal is to find a new, non-invasive way to monitor breathing support in the NICU.
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
New monitoring system aims to improve breathing tube removal in tiny preemies
Knowledge-focused Recruiting nowThis study is testing a new way to monitor very small preterm babies (born weighing less than 2.2 pounds) after their breathing tube is removed. The system combines standard vital signs with special sensors that measure oxygen levels in the brain and gut, and lung function. The g…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated May 12, 2026 13:40 UTC
-
Researchers launch major study to unlock mysteries of rare genetic disorders
Knowledge-focused Recruiting nowThis study follows 244 people with peroxisome biogenesis disorders (PBD) and related conditions over time. Researchers collect medical records, test results, and imaging to better understand how the disease progresses. The goal is to improve care and identify standards of treatme…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC
-
New study tracks eye disease in rare genetic disorder
Knowledge-focused Recruiting nowThis study follows 30 people with Zellweger Spectrum Disorder to see how their vision changes over time. Researchers will use yearly eye tests, blood work, and questionnaires to map the course of retinal degeneration. The goal is to find the best ways to monitor vision loss and p…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC
-
New study aims to cut risky pills for seniors with rheumatic disease
Knowledge-focused Recruiting nowThis study looks at whether a special tool for doctors and easy-to-read brochures for patients can help reduce the use of potentially harmful medications in adults aged 60 and older with rheumatic conditions like arthritis or lupus. Researchers will follow 100 participants for ab…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated May 07, 2026 18:38 UTC
-
Popular surgery drug may worsen Long-Term pain in breast cancer patients
Knowledge-focused Recruiting nowThis study looks at whether dexamethasone, a drug often given during mastectomy to prevent nausea, might actually increase the chance of long-term pain after surgery. Researchers will follow 170 women for three months after their operation to compare pain levels between those who…
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated May 06, 2026 16:13 UTC
-
New app aims to cut endometriosis diagnosis delays by improving Patient-Doctor communication
Knowledge-focused Recruiting nowThis study tests whether a new smartphone app called elleFA can help women with endometriosis track their symptoms and communicate better with their healthcare team. About 20 pre-menopausal women aged 18 and older with known or suspected endometriosis will use the app for 6 month…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated Apr 24, 2026 16:19 UTC